Marta Boeke

Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair

Parker L. Sulkowski, Ranjini K. Sundaram, Sebastian Oeck et al. · Nature Genetics · 2018 · 212 citations

Chromatin, Genome Instability, Dna Damage +12

A <i>KRAS</i> -Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk

Elena Ratner, Lingeng Lu, Marta Boeke et al. · Cancer Research · 2010 · 139 citations · Full text

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

Elena Ratner, Florence K. Keane, Robert Lindner et al. · Oncogene · 2011 · 82 citations · Full text

Medicine, Kras Variant, Pathology +11

Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805

Lucia B. Jilaveanu, Mäneka Puligandla, Sarah A. Weiss et al. · Clinical Cancer Research · 2017 · 32 citations · Full text

MET Inhibition in Clear Cell Renal Cell Carcinoma

Zuoquan Xie, Young Ho Lee, Marta Boeke et al. · Journal of Cancer · 2016 · 28 citations · Full text